+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Digital Decentralized Clinical Trial Solutions Market 2018-2026: How do Digital Tools Change the Way Clinical Trials are Conducted in North America and the EU?

  • PDF Icon

    Report

  • 81 Pages
  • October 2021
  • Region: Europe, North America
  • Research2Guidance
  • ID: 5591377

Landscape of Digital Decentralized Clinical Trial Solutions and Services, Market Size and Outlook, Positioning of Key Players & Trends




Overview: The Digital Decentralized Clinical Trial (DDCTs) Solutions Market 2018-2026 report provides a unique look into one of the fastest-growing digital health markets. DDCTs leverage digital tools to allow for the remote patient and provider participation in clinical trials, reducing costs, saving time on trial activities, and allowing for more diverse, patient-centric trials. The model is quickly becoming popular amongst pharma companies and other trial sponsors, and the market is expected to grow by 38.5% (CAGR) from $1,79 billion to $9,13 billion between 2021 and 2026. The report takes a deep dive into the numbers by providing a forecast for the addressable market, investment opportunities, and the number of clinical trials conducted, while also providing a deeper analysis of the leading players, business models, and trends that will continue to shape the market over the next five years.

The Digital Decentralized Clinical Trial (DDCTs) solutions market is rapidly growing and is attractive to stakeholders across the life science industry. In fact, DDCT companies have experienced a 114% growth in investments in 2020, reaching $750 million USD. Interested parties can benefit from this report in the following ways:
  • Pharmaceutical companies and trial sponsors: understand the claims and benefits proposed by DDCT solutions and be informed on which solutions may benefit their clinical research activities.
  • Investors: gain insight into the revenues of the market and the immense growth potential.
  • CROs: identify the best solution vendors and potential partners for DDCT activities and digital innovation.
  • DDCT companies: recognize key competitors within their market segment and others, learn how to better differentiate their service offering, and understand the market divided into six main groups of companies.

Questions the report answers:

  • What is the current status of the digital solutions available in the market?
  • Which countries offer the largest market?
  • Which types of service offerings will be the most successful?
  • Who are the key market players, and what is their perceived strategy?
  • What are key trends that drive the market?
  • What is the current size of the market?
  • How will the market consolidate?

The report extensively details the DDCT market structure, dividing the top 49 solutions into six groups based on the business model and service offering, while providing a detailed analysis of the challenges and benefits experienced by each group, their total market capture potential, and an outlook for their future success in the market.

The analyst has been monitoring the digital health market since 2010. This report will act as a baseline for future analyses of the digital decentralized clinical trial solutions market.

Note: The Enterprise Licence price includes a 30-minute report consultation with a research analyst

Table of Contents

1 Management Summary2 Scope3 The Value Proposition of Digital Decentralized Clinical Trial Solution Providers4 The Changing Landscape of Digital Decentralized Clinical Trial Solutions
5 The Six Archetypes of Digital Decentralized Clinical Trial Solution Providers
5.1 Archetype 1: Real World Data Solution Providers
5.2 Archetype 2: Patient Engagement Specialists
5.3 Archetype 3: Data Capture Companies
5.4 Archetype 4: Supply Chain Managers
5.5 Archetype 5: End-to-End Digital Solution Providers
5.6 Archetype 6: Digitizing CRO Incumbents
6 Market Size 2018-2026 and Top 10 Trends that will shape the DDCT Market until 20267 Strategic Outlook of DDCT Archetypes and Business Models
8 Company Profiles of Digital Clinical Trial Solution Providers
8.1 Mendel - Archetype 1
8.2 Deep6 AI - Archetype 1
8.3 SubjectWell - Archetype 2
8.4 Belong.Life - Archetype 2
8.5 AiCure - Archetype 3
8.6 Slope - Archetype 4
8.7 Marken - Archetype 4
8.8 Curebase - Archetype 5
8.9 Medable - Archetype 5
8.10 Medidata - Archetype 5
8.11 Project Baseline - Archetype 5
8.12 Parexel - Archetype 6
8.13 Iqvia - Archetype 6
9 Appendix
9.1 List of Figures and Tables
LIST OF FIGURES
Figure 1: The Virtual to Traditional Clinical Trial Spectrum
Figure 2: Impact of DDCT Solutions on a Clinical Trial Processes
Figure 3: The Digital Decentralized Clinical Trial Market Ecosystem
Figure 4: Potential Entrance of Digital Health Players in the DDCT Market
Figure 5: The Six Archetypes of DDCTs
Figure 6: Mapping of Real World Data Services of Key Competitors
Figure 7: Mapping of Patient Engagement Specialist Services of Key Competitors
Figure 8: Mapping of Clinical Trial Data Capture Services of Key Competitors
Figure 9: The Supply Chain Managers’ Patient-Centric Services and Products
Figure 10: Mapping of End-to-End Digital Clinical Trial Services of Key Competitors
Figure 11: CROs’ DDCT Service Offerings
Figure 12: Total Number of Clinical Trials and Trial Types (2018-2026, NA&EU)
Figure 13: Number of Clinical Trials Involving a DDCT Solution Compared to All Clinical Trials (2018-2026, NA&EU)
Figure 14: Number and Penetration of DDCT Supported Trial Patients and DDCT App Users Among Trial Patient Population (2018-2026, NA&EU)
Figure 15: The Investments and Money Raisers in the DDCT Market (NA & EU, 2014-2021)
Figure 16: The DDCT App Downloads, Active Users and Penetration Rate 2020-2026
Figure 17: Clinical Trial and DDCT Solution and Service Market (Million USD, NA&EU, 2018-2026)
Figure 18: Country Based Breakdown of the DDCT Market Size (Millions, NA&EU, 2018-2026)
LIST OF TABLES
Table 1: Top 6 Claims of Digital Decentralized Clinical Trial Companies
Table 2: Mendel’s AI & Machine Learning backed Service Offerings
Table 3: Deep6 AI NLP Backed Clinical Trial Matching Service Offering
Table 4: SubjectWell’s Patient Recruitment Marketplace
Table 5: Belong.Life’s Digital Services and Products
Table 6: AI Cure Patient Data Collection Engine
Table 7: Slope’s Solutions for Intelligent Supply Chain and Inventory Management
Table 8: Marken’s Suite of Products and Service for Patient-Centric Clinical Trials
Table 9: Curebase’s Technical Solution Suite
Table 10: Medable’s End-to-End Digital Offerings for Clinical Trials
Table 11: Medidata’s Selection of Products and Added Services for Clinical Trials
Table 12: The Project Baseline by Verily Products and Services for Digital Clinical Trials
Table 13: Parexel’s Digitizing Products and Services for Clinical Trials
Table 14: IQVIA’s Orchestrated Clinical Trials Solution

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aetion
  • AICure
  • AmerisourceBergen by World Courier
  • and Cegedim
  • and ICON Health
  • Belong.Life
  • Castor
  • Clara Health
  • clinCapture
  • Clinigen
  • ClinOne
  • ClinPal
  • Concert AI
  • Covance
  • Curebase
  • Datavant
  • Deep6 AI
  • Endpoint
  • Flatiron Health
  • IQVIA
  • Jumo Health
  • Lightship
  • Marken (UPS Company)
  • Medable
  • Medidata
  • medrio
  • Mendel
  • ObvioHealth
  • OpenClinica
  • Parexel
  • PatientWing
  • Pentavere
  • PPD
  • Praxis
  • Project Baseline by Verily
  • Reify Health
  • Science37
  • Seqster
  • Slope.io
  • SnapIoT
  • SubjectWell
  • Syapse
  • Syneos Health
  • Tempus
  • Thread
  • Trialspark
  • TrialX
  • uMotif
  • VirTrial (acquired by Signant Health)

Table Information